Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

Clinical trial NCT01457547 · COMPLETED

Trial details

NCT number: NCT01457547
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Poliomyelitis Diphtheria Acellular Pertussis Tetanus Haemophilus Influenzae Type b

Start date: 2003-10-01
Primary completion: 2005-05-01
Enrollment: 494

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.